Company Name: Stemline Therapeutics, Inc.    

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company is engaged in the development of therapeutics designed to target cancer stem cells and tumor bulk.

Ticker Symbol: STML (NASDAQ)

Company Website: www.stemline.com

Headquarters: New York, NY